Catalogue of collaboration profilesback to list
Sphere Fluidics Limited
Wellington House, East Road
Sphere Fluidics is a new company targeting a combined market of £27 billion in the Healthcare, Chemical Sciences and Biofuels industries.
Sphere is commercialising picodroplet technology from Cambridge University that can perform thousands of simultaneous reactions on single (and small populations of) cells and molecules contained within aqueous droplets, fractions of a millimetre in size.
This platform enables diverse applications including: miniaturised profiling of drug candidates, generation of new biocatalysts and identification of novel algal strains.
Sphere has already established commercial partnerships, won two waves of investment and believes its technology has the potential to revolutionise consumer health, the environment and future energy sources.
The Company is based in Cambridge, UK.
back to list
Miniaturised Technology and Services for Molecular and Cellular Discovery
What we offer:
Sphere Fluidics is developing patented, novel microfluidics systems, surface chemistry and detection interfaces for automated, picodroplet analysis.
The Company provides specialised Research Collaborations and Products for Cell Biology and Proteomics studies in the Healthcare, Biofuels and Chemical Sciences markets.
What are we looking for:
Sphere is looking for:
1) Potential clients.
2) Technology development partners.
3) Strategic alliance partners.
- Research & Development
- Technical Co-operation
- Joint Venture Agreement
- Commercial Agreement